BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9880385)

  • 1. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.
    Demchuk AM; Morgenstern LB; Krieger DW; Linda Chi T; Hu W; Wein TH; Hardy RJ; Grotta JC; Buchan AM
    Stroke; 1999 Jan; 30(1):34-9. PubMed ID: 9880385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
    Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
    Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.
    Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M
    Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
    Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
    Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis.
    Kidwell CS; Saver JL; Carneado J; Sayre J; Starkman S; Duckwiler G; Gobin YP; Jahan R; Vespa P; Villablanca JP; Liebeskind DS; Vinuela F
    Stroke; 2002 Mar; 33(3):717-24. PubMed ID: 11872894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
    Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL
    Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhage in the Interventional Management of Stroke study.
    IMS Study Investigators
    Stroke; 2006 Mar; 37(3):847-51. PubMed ID: 16439694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.
    Derex L; Hermier M; Adeleine P; Pialat JB; Wiart M; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P; Nighoghossian N
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):70-5. PubMed ID: 15607998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke.
    Dharmasaroja PA; Muengtaweepongsa S; Pattaraarchachai J; Dharmasaroja P
    J Clin Neurosci; 2012 Jun; 19(6):799-803. PubMed ID: 22472785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke.
    Natarajan SK; Dandona P; Karmon Y; Yoo AJ; Kalia JS; Hao Q; Hsu DP; Hopkins LN; Fiorella DJ; Bendok BR; Nguyen TN; Rymer MM; Nanda A; Liebeskind DS; Zaidat OO; Nogueira RG; Siddiqui AH; Levy EI
    J Neurosurg; 2011 Jun; 114(6):1785-99. PubMed ID: 21351835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
    Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
    Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis.
    Lou M; Safdar A; Mehdiratta M; Kumar S; Schlaug G; Caplan L; Searls D; Selim M
    Neurology; 2008 Oct; 71(18):1417-23. PubMed ID: 18955684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
    Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.